Cholamandalam Investment and Finance Company (511243) Q2 22/23 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 22/23 earnings summary
16 Oct, 2026Executive summary
Q2 FY23 disbursements reached a record ₹14,623 Cr, up 68% YoY; AUM rose 22% to ₹91,841 Cr.
Q2 PAT was ₹563 Cr, down 7% YoY against an unusually low credit-loss comparator; H1 PAT rose 21% to ₹1,129 Cr.
Financial highlights
Q2 total income was ₹3,038 Cr, up 22% YoY; net income reached ₹1,697 Cr, up 21%.
Q2 finance costs increased 24% YoY to ₹1,340 Cr; total expenses rose 28% to ₹661 Cr and loan losses were ₹278 Cr versus ₹69 Cr.
H1 total income was ₹5,809 Cr, up 17%; net income was ₹3,337 Cr, up 20%, and PAT was ₹1,129 Cr, up 21%.
Consolidated Q2 profit before tax was ₹759 Cr and profit after tax ₹563 Cr; H1 consolidated PAT was ₹1,125 Cr.
Outlook and guidance
Record quarterly disbursements and diversified products were expected to support momentum into the festival season.
IMF projected India FY23 growth of 6.8%; global demand slowdown, inflation, higher interest rates and a stronger US dollar were cited as headwinds.
Latest events from Cholamandalam Investment and Finance Company
- Q2 disbursements rose 47%, PAT 41%, and a QIP of up to ₹5,000 crore was approved.511243
Q2 26/27 - Robust financials, a forceful rebuttal and improving Q3 disbursement momentum.511243Status update
- PPOP grew 56%, but pandemic-driven loan losses cut Q1 PAT 24%.511243Q1 21/22
- Strong Q2 growth and improving asset quality, with COVID-related credit risk still elevated.511243Q2 21/22
- Disbursements jumped 267% and PAT grew 73%, with Stage 3 improving to 4.16%.511243Q1 22/23
- Q3 disbursements +68%, AUM +31% and standalone PAT +31% YoY.511243Q3 22/23
- Disbursements surged 50% as higher funding costs tempered Q1 profit growth.511243Q1 23/24
- FY22 profit rose 42% as record disbursements fueled lending growth.511243Q4 21/22
- Record FY23 lending growth and improved asset quality supported higher profit.511243Q4 22/23